Strengthening pharmacovigilance and regulatory capacity in Southern Africa (SPaRCS): achievements, experiences and lessons learned from a participatory action learning project. [PDF]
Front Drug Saf RegulViljoen M +10 more
europepmc +1 more source
Bruton tyrosine kinase inhibitors and cardiovascular adverse events
British Journal of Pharmacology, EarlyView.Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli +4 more
wiley +1 more source
Correction: Artificial Intelligence-Driven Skin Parameter Assessment in Indian Adults: Establishing Population-Specific Reference Data for Clinical Dermatology. [PDF]
CureusArora S, Arora N, Karwa M, Reddy ST.
europepmc +1 more source
Cancer Science, EarlyView.This article reports on the clinical and imaging features of tepotinib‐induced interstitial lung disease (ILD), which were evaluated by an ILD adjudication committee composed of external respiratory and radiology experts, and the committee expertly identified 35 patients with tepotinib‐induced ILD from spontaneous adverse event reports accumulated in ...
Terufumi Kato +5 more
wiley +1 more source
Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports. [PDF]
Medicine (Baltimore)Alorfi NM +9 more
europepmc +1 more source
Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use—A Scoping Review
Clinical &Experimental Allergy, EarlyView.Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Jun Jie Benjamin Seng +2 more
wiley +1 more source
Strengthening pharmacovigilance through patient reporting: a scoping review of awareness, barriers, and facilitators. [PDF]
J Pharm Policy PractAslam A +4 more
europepmc +1 more source
Contact Dermatitis, EarlyView.ABSTRACT The present guideline updates the initial ESCD patch testing guideline, summarizing all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions
Wolfgang Uter +23 more
wiley +1 more source
Cardiotoxicity in dual immune checkpoint inhibitors: a critical appraisal of signal interpretation and future directions. [PDF]
Eur Heart J Cardiovasc PharmacotherDong W, Song Q, Wang Q.
europepmc +1 more source